Fig. 1From: Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugsCirculating calprotectin levels (ng/mL) at the moment of DMARD tapering/stopping, separated by whether patients experienced a disease flare within 12 months of tapering. p values were calculated by Mann-Whitney U testsBack to article page